A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Viatris Inc stock. As of the latest transaction made, Bridgewater Associates, LP holds 522,461 shares of VTRS stock, worth $5.54 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
522,461
Previous 155,987 234.94%
Holding current value
$5.54 Million
Previous $1.69 Million 269.33%
% of portfolio
0.03%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$11.27 - $13.53 $4.13 Million - $4.96 Million
366,474 Added 234.94%
522,461 $6.24 Million
Q4 2023

Feb 14, 2024

SELL
$8.77 - $10.85 $531,155 - $657,130
-60,565 Reduced 27.97%
155,987 $1.69 Million
Q3 2023

Nov 13, 2023

SELL
$9.59 - $11.35 $1.14 Million - $1.34 Million
-118,407 Reduced 35.35%
216,552 $2.14 Million
Q2 2023

Aug 11, 2023

SELL
$9.02 - $10.29 $1 Million - $1.14 Million
-111,234 Reduced 24.93%
334,959 $3.34 Million
Q1 2023

May 12, 2023

SELL
$9.2 - $12.26 $1.13 Million - $1.51 Million
-122,901 Reduced 21.6%
446,193 $4.29 Million
Q4 2022

Feb 13, 2023

BUY
$8.72 - $11.56 $684,197 - $907,032
78,463 Added 15.99%
569,094 $6.33 Million
Q3 2022

Nov 10, 2022

SELL
$8.48 - $11.13 $1.7 Million - $2.23 Million
-200,578 Reduced 29.02%
490,631 $4.18 Million
Q2 2022

Aug 11, 2022

BUY
$9.95 - $12.27 $2.7 Million - $3.33 Million
271,140 Added 64.55%
691,209 $7.24 Million
Q1 2022

May 13, 2022

BUY
$9.81 - $15.4 $1.64 Million - $2.58 Million
167,264 Added 66.16%
420,069 $4.57 Million
Q4 2021

Feb 14, 2022

BUY
$12.09 - $14.68 $71,246 - $86,509
5,893 Added 2.39%
252,805 $3.42 Million
Q3 2021

Nov 12, 2021

SELL
$13.25 - $15.13 $660,221 - $753,897
-49,828 Reduced 16.79%
246,912 $3.35 Million
Q2 2021

Aug 13, 2021

BUY
$12.97 - $16.15 $3.31 Million - $4.12 Million
255,408 Added 617.94%
296,740 $4.24 Million
Q1 2021

May 14, 2021

BUY
$13.59 - $18.54 $561,701 - $766,295
41,332 New
41,332 $577,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $12.9B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track Ray Dalio's Portfolio

Track Ray Dalio Portfolio

Follow Ray Dalio (Bridgewater Associates, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.